Goat anti-LRRK2 / PARK8 (near C Terminus)

EB06550
ApplicationsImmunoFluorescence, ELISA
Product group Antibodies
ReactivityHuman
TargetLRRK2
Product EB06550 is not available
Product not available
There may be an alternative product available, please contact our technical support team.
Overview
- SupplierEverest Biotech
- Product NameGoat anti-LRRK2 / PARK8 (near C Terminus) Antibody
- Delivery Days Customer7
- Application Supplier NoteImmunofluorescence: Strong expression of the protein seen in the vesicles of A431 cells and in the vesicles and nuclei of A549 cells. Recommended concentration: 10microg/ml.
- ApplicationsImmunoFluorescence, ELISA
- Applications SupplierPep-ELISA, IF
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- Gene ID120892
- Target nameLRRK2
- Target descriptionleucine rich repeat kinase 2
- Target synonymsaugmented in rheumatoid arthritis 17; AURA17; DARDARIN; leucine-rich repeat serine/threonine-protein kinase 2; PARK8; RIPK7; ROCO2
- HostGoat
- Scientific DescriptionRefSeq number(s): NP_940980.3. Purification: Antigen affinity purified. Names and symbols: LRRK2; PARK8; ROCO2; FLJ45829; DKFZp434H2111; leucine-rich repeat kinase 2; dardarin; Parkinson disease (autosomal dominant) 8; AURA17; DARDARIN; RIPK7; augmented in rheumatoid arthritis 17
- ReactivityHuman
- Reactivity SupplierHuman
- Storage Instruction-20°C
- UNSPSC12352203
References
- LRRK2 expression in idiopathic and G2019S positive Parkinsons disease subjects: a morphological and quantitative study. Sharma S et al., 2011 Dec, Neuropathol Appl NeurobiolRead more
- LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Alegre-Abarrategui J et al., 2009 Nov 1, Hum Mol GenetRead more
- LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinsons disease. Alegre-Abarrategui J et al., 2008 Jun, Neuropathol Appl NeurobiolRead more